UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 218

Sortiert nach

Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study

The Lancet infectious diseases, 2011-05, Vol.11 (5), p.363-371

2011

Link zum Volltext

Verfügbarkeit prüfen

Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy

AIDS (London), 2014-05, Vol.28 (8), p.1193-1202

2014

Link zum Volltext

Verfügbarkeit prüfen

Beyond viral suppression of HIV - the new quality of life frontier

BMC medicine, 2016-06, Vol.14 (1), p.94-94, Article 94

2016

Link zum Volltext

Verfügbarkeit prüfen

Mass drug administration for endemic scabies: a systematic review

Tropical diseases, travel medicine and vaccines, 2021-07, Vol.7 (1), p.1-21, Article 21

2021

Link zum Volltext

Verfügbarkeit prüfen

HIV-1 molecular transmission clusters in nine European countries and Canada: association with demographic and clinical factors

BMC medicine, 2019-01, Vol.17 (1), p.4-4, Article 4

2019

Link zum Volltext

Verfügbarkeit prüfen

An evaluation of HIV elite controller definitions within a large seroconverter cohort collaboration

PloS one, 2014-01, Vol.9 (1), p.e86719-e86719

2014

Link zum Volltext

Verfügbarkeit prüfen

Duration of HIV-1 viral suppression on cessation of antiretroviral therapy in primary infection correlates with time on therapy

PloS one, 2013-10, Vol.8 (10), p.e78287-e78287

2013

Link zum Volltext

Verfügbarkeit prüfen

From HIV infection to therapeutic response: a population-based longitudinal HIV cascade-of-care study in KwaZulu-Natal, South Africa

The lancet HIV, 2017-05, Vol.4 (5), p.e223-e230

2017

Link zum Volltext

Verfügbarkeit prüfen

CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNA

Frontiers in immunology, 2018-05, Vol.9, p.928-928

2018

Link zum Volltext

Verfügbarkeit prüfen

HIV Testing and Diagnosis Rates in Kiev, Ukraine: April 2013-March 2014

PloS one, 2015-08, Vol.10 (8), p.e0137062-e0137062

2015

Link zum Volltext

Verfügbarkeit prüfen

CASCADE protocol: exploring current viral and host characteristics, measuring clinical and patient-reported outcomes, and understanding the lived experiences and needs of individuals with recently acquired HIV infection through a multicentre mixed-methods observational study in Europe and Canada

BMJ open, 2023-05, Vol.13 (5), p.e070837-e070837

2023

Link zum Volltext

Verfügbarkeit prüfen

Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection

PloS one, 2012-08, Vol.7 (8), p.e43754-e43754

2012

Link zum Volltext

Verfügbarkeit prüfen

HIV Incidence Estimates Using the Limiting Antigen Avidity EIA Assay at Testing Sites in Kiev City, Ukraine: 2013-2014

PloS one, 2016-06, Vol.11 (6), p.e0157179-e0157179

2016

Link zum Volltext

Verfügbarkeit prüfen

The effect of short-course antiretroviral therapy initiated in primary HIV-1 infection on interleukin-6 and D-dimer levels

AIDS (London), 2015-07, Vol.29 (11), p.1355-1361

2015

Link zum Volltext

Verfügbarkeit prüfen

Temporal Trends in Postseroconversion CD4 Cell Count and HIV Load: The Concerted Action on Seroconversion to AIDS and Death in Europe Collaboration, 1985–2002

The Journal of infectious diseases, 2007-02, Vol.195 (4), p.525-534

2007

Link zum Volltext

Verfügbarkeit prüfen

Spontaneous control of viral load and CD4 cell count progression among HIV-1 seroconverters

AIDS (London), 2005-11, Vol.19 (17), p.2001-2007

2005

Link zum Volltext

Verfügbarkeit prüfen

Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating antiretroviral therapy--the CASCADE collaboration: a collaboration of 23 cohort studies

PLoS medicine, 2010-02, Vol.7 (2), p.e1000239-e1000239

2010

Link zum Volltext

Verfügbarkeit prüfen

Symptomatic illness and low CD4 cell count at HIV seroconversion as markers of severe primary HIV infection

PloS one, 2013-11, Vol.8 (11), p.e78642-e78642

2013

Link zum Volltext

Verfügbarkeit prüfen

Gender Differences in HIV Progression to AIDS and Death in Industrialized Countries: Slower Disease Progression Following HIV Seroconversion in Women

American journal of epidemiology, 2008-09, Vol.168 (5), p.532-540

2008

Link zum Volltext

Verfügbarkeit prüfen

The Impact of HCV Infection Duration on HIV Disease Progression and Response to cART amongst HIV Seroconverters in the UK

PloS one, 2015-07, Vol.10 (7), p.e0132772-e0132772

2015

Link zum Volltext

Verfügbarkeit prüfen

Differences in HIV natural history among African and non-African seroconverters in Europe and seroconverters in sub-Saharan Africa

PloS one, 2012-03, Vol.7 (3), p.e32369-e32369

2012

Link zum Volltext

Verfügbarkeit prüfen

Health system capacity to report on indicators fostering integrated people-centred HIV care: findings from six European countries

International journal of integrated care, 2019-08, Vol.19 (4), p.483

2019

Link zum Volltext

Verfügbarkeit prüfen

Virologic and immunologic response to cART by HIV-1 subtype in the CASCADE collaboration

PloS one, 2013-07, Vol.8 (7), p.e71174-e71174

2013

Link zum Volltext

Verfügbarkeit prüfen

Temporal trends in prognostic markers of HIV-1 virulence and transmissibility: an observational cohort study

The lancet HIV, 2014-12, Vol.1 (3), p.e119-e126

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 218

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(213)
Mit Volltextzugriff
(184)

Publikationsform

Artikel
(218)

Sprache

Englisch
(218)
Japanisch
(17)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study

Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy

Beyond viral suppression of HIV - the new quality of life frontier

Mass drug administration for endemic scabies: a systematic review

HIV-1 molecular transmission clusters in nine European countries and Canada: association with demographic and clinical factors

An evaluation of HIV elite controller definitions within a large seroconverter cohort collaboration

Duration of HIV-1 viral suppression on cessation of antiretroviral therapy in primary infection correlates with time on therapy

From HIV infection to therapeutic response: a population-based longitudinal HIV cascade-of-care study in KwaZulu-Natal, South Africa

CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNA

HIV Testing and Diagnosis Rates in Kiev, Ukraine: April 2013-March 2014

CASCADE protocol: exploring current viral and host characteristics, measuring clinical and patient-reported outcomes, and understanding the lived experiences and needs of individuals with recently acquired HIV infection through a multicentre mixed-methods observational study in Europe and Canada

Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection

HIV Incidence Estimates Using the Limiting Antigen Avidity EIA Assay at Testing Sites in Kiev City, Ukraine: 2013-2014

The effect of short-course antiretroviral therapy initiated in primary HIV-1 infection on interleukin-6 and D-dimer levels

Temporal Trends in Postseroconversion CD4 Cell Count and HIV Load: The Concerted Action on Seroconversion to AIDS and Death in Europe Collaboration, 1985–2002

Spontaneous control of viral load and CD4 cell count progression among HIV-1 seroconverters

Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating antiretroviral therapy--the CASCADE collaboration: a collaboration of 23 cohort studies

Symptomatic illness and low CD4 cell count at HIV seroconversion as markers of severe primary HIV infection

Gender Differences in HIV Progression to AIDS and Death in Industrialized Countries: Slower Disease Progression Following HIV Seroconversion in Women

The Impact of HCV Infection Duration on HIV Disease Progression and Response to cART amongst HIV Seroconverters in the UK

Differences in HIV natural history among African and non-African seroconverters in Europe and seroconverters in sub-Saharan Africa

Health system capacity to report on indicators fostering integrated people-centred HIV care: findings from six European countries

Correction: Viral genetic variation accounts for a third of variability in HIV-1 set-point viral load in Europe

Virologic and immunologic response to cART by HIV-1 subtype in the CASCADE collaboration

Temporal trends in prognostic markers of HIV-1 virulence and transmissibility: an observational cohort study

Suchergebnisse filtern